Abstract:Stevens-Johnson syndrome is a type of severe drug eruption, which is characterized by rapid onset and rapid progress. If not treated in time, it can develop into toxic epidermal necrolysis, even life-threatening. Common sensitizing drugs include sulfa, carbamazepine, etc. In China, reports and studies of carbamazepine causing Stevens-Johnson syndrome mainly focus on the HLA-B * 1502 gene, and there are no reports of HLA-A * 3101 gene positive. We reported a patient who got Stevens-Johnson syndrome with HLA-A * 3101 gene positive caused by carbamazepine. She took carbamazepine for trigeminal neuralgia and had never taken the drug before. After 2 weeks, papules and edematous target-like erythema gradually appeared on the trunk and limbs, surface blisters and scabs, and the oral, eyes, and vulvar mucosa appeared erosion, accompanied by fever and pain, with an area of about 3% exfoliation. She was diagnosed with Stevens-Johnson syndrome and admitted to Peking University Third Hospital on March 24, 2020. After admission, in order to identify the sensitizing drugs, We performed a genetic test on her for carbamazepine-related drugs. The results showed that the HLA-A * 3101 gene was positive, and the HLA-B * 1502 and HLA-B * 5801 genes were negative. In terms of treatment, the patient was systematically given a single intravenous infusion of 300 mg of infliximab, and symptomatic treatment and care of the oral, eye, and vulvar mucosa. After 6 days, the rash on the trunk and limbs subsided, and the mucosa returned to normal and was discharged from the hospital. Retrieving domestic and foreign literature, it is not uncommon to report that carbamazepine causes drug eruption, including severe drug eruption, and there are obvious ethnic differences in the pathogenicity of HLA genotyping. In China and Asia, stu-dies on carbamazepine causing Stevens-Johnson syndrome emphasized that the adverse reactions were strongly related to the HLA-B * 1502 gene. However, there is a strong correlation with HLA-A * 3101 gene in people suffering from the disease in Europe and Japan. In this case report, the HLA-B * 1502 gene was negative and the HLA-A * 3101 gene was positive. This is the first domestic report that carba-mazepine causes HLA-A * 3101 positive for Stevens-Johnson syndrome. This report reminds that HLA-A * 3101 gene testing should be taken seriously besides HLA-B * 1502 gene.

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

Strong Association Between HLA-B*1502 and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Mainland Han Chinese Patients

Association Between the HLA-B*15:02 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome/toxic Epidermal Necrolysis in Han Individuals of Northeastern China.

A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN

Association Study of Lamotrigine-Induced Cutaneous Adverse Reactions and HLA-B*1502 in a Han Chinese Population

Pilot Association Study of Oxcarbazepine-Induced Mild Cutaneous Adverse Reactions with HLA-B*1502 Allele in Chinese Han Population

Predictive Markers for Carbamazepine and Lamotrigine-Induced Maculopapular Exanthema in Han Chinese

Genetic Predictors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Aromatic Antiepileptic Drugs among the Chinese Han Population

Study on the Relationship Between Adverse Drug Reactions of Carbamazepine and HLA-B*1502 Genetic Polymorphism and Blood Concentration

[Carbamazepine induced Stevens-Johnson syndrome in Han Chinese with positive HLA-A * 3101 gene: A case report]

The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a Northern Han Chinese population

Phenytoin-induced Stevens–Johnson Syndrome with Negative HLA-B*1502 Allele in Mainland China: Two Cases

Association Between HLA-A*3201 Allele and Oxcarbazepine-Induced Cutaneous Adverse Reactions in Eastern Han Chinese Population

The association between AED-induced cutaneous adverse drug reactions and the HLA-A, -B, and -DRB1 alleles among Caucasian patients: a pilot multicenter study

HLA-B*13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?

Hla-A*24:02 As A Common Risk Factor for Antiepileptic Drug-Induced Cutaneous Adverse Reactions

Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans

Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions

Association Between HLA-B∗46:01 and Cutaneous Adverse Drug Reactions in Han Chinese

HLA-B*59:01: a Marker for Stevens–Johnson Syndrome/toxic Epidermal Necrolysis Caused by Methazolamide in Han Chinese

Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti‐seizure medications